These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25498031)

  • 1. Mesenchymal properties of SJL mice-stem cells and their efficacy as autologous therapy in a relapsing-remitting multiple sclerosis model.
    Marin-Bañasco C; Suardíaz García M; Hurtado Guerrero I; Maldonado Sánchez R; Estivill-Torrús G; Leyva Fernández L; Fernández Fernández O
    Stem Cell Res Ther; 2014 Dec; 5(6):134. PubMed ID: 25498031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
    Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
    Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of AD-MSC (adipose-derived mesenchymal stem cells) as a vehicle for IFN-β delivery in experimental autoimmune encephalomyelitis.
    Mohammadzadeh A; Pourfathollah AA; Shahrokhi S; Fallah A; Tahoori MT; Amari A; Forouzandeh M; Soleimani M
    Clin Immunol; 2016 Aug; 169():98-106. PubMed ID: 27373971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosis.
    Marin-Bañasco C; Benabdellah K; Melero-Jerez C; Oliver B; Pinto-Medel MJ; Hurtado-Guerrero I; de Castro F; Clemente D; Fernández O; Martin F; Leyva L; Suardíaz M
    Br J Pharmacol; 2017 Feb; 174(3):238-253. PubMed ID: 27882538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE).
    Yousefi F; Ebtekar M; Soleimani M; Soudi S; Hashemi SM
    Int Immunopharmacol; 2013 Nov; 17(3):608-16. PubMed ID: 23973288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis.
    Cobo M; Anderson P; Benabdellah K; Toscano MG; Muñoz P; García-Pérez A; Gutierrez I; Delgado M; Martin F
    Cell Transplant; 2013; 22(5):839-54. PubMed ID: 23031550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
    Kassis I; Petrou P; Halimi M; Karussis D
    Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Adipose Stromal/Stem Cells from Obese Donors Show Reduced Efficacy in Halting Disease Progression in the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
    Strong AL; Bowles AC; Wise RM; Morand JP; Dutreil MF; Gimble JM; Bunnell BA
    Stem Cells; 2016 Mar; 34(3):614-26. PubMed ID: 26700612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted Mice.
    Abramowski P; Krasemann S; Ernst T; Lange C; Ittrich H; Schweizer M; Zander AR; Martin R; Fehse B
    Stem Cells Dev; 2016 Aug; 25(15):1134-48. PubMed ID: 27250994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
    Yaochite JN; Caliari-Oliveira C; de Souza LE; Neto LS; Palma PV; Covas DT; Malmegrim KC; Voltarelli JC; Donadi EA
    Stem Cell Res Ther; 2015 Mar; 6(1):31. PubMed ID: 25884215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
    Liao W; Pham V; Liu L; Riazifar M; Pone EJ; Zhang SX; Ma F; Lu M; Walsh CM; Zhao W
    Biomaterials; 2016 Jan; 77():87-97. PubMed ID: 26584349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model.
    Zhang X; Bowles AC; Semon JA; Scruggs BA; Zhang S; Strong AL; Gimble JM; Bunnell BA
    PLoS One; 2014; 9(1):e85007. PubMed ID: 24465465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis.
    Yu JW; Li YH; Song GB; Yu JZ; Liu CY; Liu JC; Zhang HF; Yang WF; Wang Q; Yan YP; Xiao BG; Ma CG
    J Mol Neurosci; 2016 Dec; 60(4):486-497. PubMed ID: 27573128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis.
    Constantin G; Marconi S; Rossi B; Angiari S; Calderan L; Anghileri E; Gini B; Bach SD; Martinello M; Bifari F; Galiè M; Turano E; Budui S; Sbarbati A; Krampera M; Bonetti B
    Stem Cells; 2009 Oct; 27(10):2624-35. PubMed ID: 19676124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model.
    Fernández-García M; Yañez RM; Sánchez-Domínguez R; Hernando-Rodriguez M; Peces-Barba M; Herrera G; O'Connor JE; Segovia JC; Bueren JA; Lamana ML
    Stem Cell Res Ther; 2015 Sep; 6(1):165. PubMed ID: 26345192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose-derived mesenchymal stem cells modulate the immune response in chronic experimental autoimmune encephalomyelitis model.
    Shalaby SM; Sabbah NA; Saber T; Abdel Hamid RA
    IUBMB Life; 2016 Feb; 68(2):106-15. PubMed ID: 26757144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of multipotent adult progenitor cells versus mesenchymal stem cells in experimental autoimmune encephalomyelitis.
    Singh SP; Jadhav SH; Chaturvedi CP; Nityanand S
    Regen Med; 2017 Apr; 12(4):377-396. PubMed ID: 28621170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
    Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
    Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro simulation of corneal epithelium microenvironment induces a corneal epithelial-like cell phenotype from human adipose tissue mesenchymal stem cells.
    Nieto-Miguel T; Galindo S; Reinoso R; Corell A; Martino M; Pérez-Simón JA; Calonge M
    Curr Eye Res; 2013 Sep; 38(9):933-44. PubMed ID: 23767776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
    Donders R; Vanheusden M; Bogie JF; Ravanidis S; Thewissen K; Stinissen P; Gyselaers W; Hendriks JJ; Hellings N
    Cell Transplant; 2015; 24(10):2077-98. PubMed ID: 25310756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.